Omkar Pharmachem Share Price

Omkar Pharmachem

CMP as on23-Dec-20 15:37

₹ 18.00
0 0%

Open

₹ 17.15

Turnover (lac)

Prev. Close

₹ 0.00

Day's Vol (shares)

₹ 1,110

Day's Range

₹ 17.15
₹ 18.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 02-Nov-2020 - -
OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve and take on record the Unaudited Financial Results of the Company for the Quarter and half year ended on 30th September, 2020. Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 12th November, 2020 has Considered and approved: Unaudited Financial Results of the Company along with Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report for the Quarter and half year ended on 30th September, 2020. (As per BSE Announcement Dated on 12/11/2020)
Board Meeting - 07-Sep-2020 - -
Quarterly Results Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in its meeting held on 15th September, 2020 has Considered and approved: Unaudited Financial Results of the Company for the quarter ended on 30th June, 2020 along with Limited Review Report of the Company. (As per BSE Announcement Dated on 15/9/2020)
Board Meeting - 01-Sep-2020 - -
Dear Sir/Maam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) LODR Regulations, 2015, this is to inform the Exchange that the Board of Directors in its meeting held on today i.e. 31st August, 2020 has consider and approved inter alia the following: 1.Notice of 25th Annual General Meeting of the Shareholders of the Company to be held on Tuesday, 29th September, 2020 at 11:30 AM at the registered office of the Company. 2.Closure of Register of Members and share transfer books of the Company from Wednesday, 23rd Day of September, 2020 to Tuesday, 29th Day of September, 2020 (both days inclusive), 3.Re-appointment of Mr. Janak Raj Sharma as Independent Director for second term of five financial Year. 4.Approval of Alteration of Object Clause of the Memorandum of Association of the company 5.Approval of Directors report along with the annexure(s) thereto for the financial year ended on 31st March 2020.
Board Meeting - 20-Jun-2020 - -
OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2020 ,inter alia, to consider and approve Audited Financial Results of the Company for the Quarter and financial year ended on 31st March, 2020. Outcome of Board Meeting held on June 29,2020. (As Per BSE Announcement Dated on 29/06/2020)
Board Meeting - 04-Feb-2020 - -
OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2020 ,inter alia, to consider and approve Dear Sir(s), Pursuant to Regulations 29(1)(a) of SEBI (LODR) Regulations 2015 notice is hereby given that a meeting of Board of Directors of Omkar Pharmachem Limited will be held on Friday, 14th February, 2020 at 04:30 P.M. at the registered office of the Company inter alia; To consider, approve and take on record the Un-audited Financial Results of the Company alongwith Limited Review Report for the third Quarter and Nine months ended 31st December, 2019 Further, in continuation to our Intimation dated December 30, 2019 regarding closure of trading window for dealing in shares of the Company, we hereby inform you that pursuant to the Code of Conduct to Regulate, Monitor and Report Trading in Securities of the Company, the trading window for dealing in shares of the Company shall continue to remain closed till February 16, 2020, for all the Designated Persons of the Company and their Immediate Relatives. Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in its meeting held on 14th February, 2020 has considered and approved the following business: 1.Appointment of Mr. Bhawani Shankar Goyal as additional cum Managing Director of the company with immediate effect. 2.Un-audited Financial Results of the Company along with Limited Review Report for the quarter and Nine Months ended on 31st December, 2019. Further, it is hereby confirmed that Mr. Bhawani Shankar Goyal is not debarred from holding the office of the Director by virtue of any SEBI order or any other such authority. (As Per BSE Announcement Dated on 14/02/2020)